Financials

  • Market Capitalization 1.6262 B
  • Employee 493
  • Founded 2008
  • CEO Bahija Jallal
  • Website www.immunocore.com
  • Headquarter United Kingdom
  • FIGI BBG00YYCXFB9
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-48.89
Price to sales ratio
4.37
Dividends per share
Dividend yield %

Immunocore Holdings plc - American Depositary Shares

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Haberler